The clinical potential of fourth-generation cephalosporins

Diagnostic Microbiology and Infectious Disease

Volumn 31, Issue 3, 1998, Pages 479-480

  Garau, Javier ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFCLIDIN; CEFEPIME; CEFLUPRENAM; CEFOSELIS; CEFOZOPRAN; CEFPIROME;

BACTERICIDAL ACTIVITY; CONFERENCE PAPER; DRUG USE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION;

BACTERIAL INFECTIONS; CEPHALOSPORINS; CLINICAL TRIALS; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031776789     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00035-2     Document Type: Conference Paper

References (1)

1. Hancock R.E.W., Bellido F. Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother. 29:(suppl A):1992;1-6.